$TECH 4/A SEC Filings

Filed On	Filing
11 Apr 2025	Form 4/A: Vessey Rupert, Director Granted 588 Stock Options (Right to Buy)
03 Feb 2025	Form 4/A: McManus Matthew, President - DGS Granted 15,825 Performance Restricted Stock Units
14 Dec 2023	Form 4/A: Geist William, PRESIDENT, PROTEIN SCIENCES Granted 9,074 Restricted Stock Units · Granted 24,424 Stock Options (Right to Buy)
14 Dec 2023	Form 4/A: Bohnen Shane, SVP - General Counsel Granted 4,802 Restricted Stock Units · Granted 12,924 Stock Option (Right to Buy)
14 Dec 2023	Form 4/A: Kelderman Kim, Pres. Diagnostics & Genom Granted 8,873 Restricted Stock Units · Granted 23,881 Stock Options (Right to Buy)
14 Dec 2023	Form 4/A: Hippel James, CFO Granted 13,865 Restricted Stock Units · Granted 37,314 Stock Options (Right to Buy)
09 Nov 2023	Form 4/A: Geist William, PRESIDENT, PROTEIN SCIENCES Granted 19,823 Restricted Stock Units
24 Aug 2023	Form 4/A: Bohnen Shane, SVP - General Counsel Granted 148 Restricted Stock Units · Granted 16,302 Stock Option (Right to Buy)
29 Sep 2022	Form 4/A: Geist William, President, Protein Sciences Granted 2,490 Restricted Stock Units
13 Nov 2020	Form 4/A: Hippel James, Chief Financial Officer Exercised 7,391 Stock Option (Right to Buy)
12 Nov 2020	Form 4/A: Hippel James, Chief Financial Officer Exercised 8,809 Stock Options (Right to Buy)
20 Aug 2015	Form 4/A: Eansor Norman David, SVP - Novus Biologicals Granted 9,375 Stock Option (Right to Buy) · Granted 1,500 Restricted Stock Units
20 Aug 2015	Form 4/A: Gavin Robert M., Senior V.P. Protein Platforms Granted 9,375 Stock Option (Right to Buy) · Granted 1,500 Restricted Stock Units
20 Aug 2015	Form 4/A: Veronneau Marcel, SVP - Clinical Controls Granted 5,625 Stock Option (Right to Buy) · Granted 900 Restricted Stock Units
20 Aug 2015	Form 4/A: Furlow Brenda S., SVP - General Counsel Granted 1,200 Restricted Stock Units · Granted 7,500 Stock Option (Right to Buy)
20 Aug 2015	Form 4/A: Kummeth Charles R., Director Granted 119,275 Stock Option (Right to Buy) · Granted 17,283 Restricted Stock Unit
20 Aug 2015	Form 4/A: Bazan J. Fernando, Chief Technical Officer Granted 7,500 Stock Options (Right to Buy) · Granted 1,200 Restricted Stock Units
20 Aug 2015	Form 4/A: Hippel James, Chief Financial Officer Granted 18,750 Stock Option (Right to Buy) · Granted 3,000 Restricted Stock Unit
08 Aug 2013	Form 4/A: Bazan J. Fernando, Chief Technical Officer Granted 25,000 Stock Option (Right to Buy)
06 Dec 2011	Form 4/A: Oland Thomas E, Director Gave 2,000 shares as a gift ($135K)

Comments